Cancer Clinical Trials: Implications for Oncology Nurses

被引:5
|
作者
Portier, Wendy S. [1 ]
机构
[1] Portier & Associates LLC, New Orleans, LA USA
关键词
clinical trial; Food and Drug Administration; biomarker; informed consent; protocol; adverse event; clinical trial navigator;
D O I
10.1016/j.soncn.2020.150998
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To explore the various types and phases of clinical trials, the regulatory oversight, drug approval process, and implications of clinical trials for the oncology nurse. Data Sources: Peer-reviewed journal articles, internet, book chapters, white papers. Conclusion: Oncology nurses' interactions with patients entered on clinical trial and communication with the clinical research team is crucial to the successful conduct of clinical trials. The oncology nurse must work in concert with the clinical research team to protect patient safety and to produce accurate information for protocol requirements that will be used to evaluate whether a drug becomes approved or not by the US Food and Drug Administration. Implications for Nursing Practice: Oncology nurses play a central role to the successful outcome of clinical research studies. Nurses must work in close collaboration with the clinical research teams for the successful completion and adherence of the clinical trial and to maintain the safety of the patient enrolled into clinical trial. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Clinical Trials and the Role of the Oncology Clinical Trials Nurse
    Ness, Elizabeth A.
    Royce, Cheryl
    NURSING CLINICS OF NORTH AMERICA, 2017, 52 (01) : 133 - +
  • [32] Ambra1 in cancer: implications for clinical oncology
    Yan-qiu Qin
    Si-yu Liu
    Mei-ling Lv
    Wei-liang Sun
    Apoptosis, 2022, 27 : 720 - 729
  • [33] Ambra1 in cancer: implications for clinical oncology
    Qin, Yan-qiu
    Liu, Si-yu
    Lv, Mei-ling
    Sun, Wei-liang
    APOPTOSIS, 2022, 27 (9-10) : 720 - 729
  • [34] Drug Shortages Strain Cancer Treatment and Oncology Clinical Trials
    Boughton, Barbara
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2011, 4 (06): : 397 - 397
  • [35] Expanded treatment options in the adjuvant therapy of colon cancer: Implications for oncology nurses
    Viale, PH
    ONCOLOGY NURSING FORUM, 2006, 33 (01) : 81 - 90
  • [36] African American Participation in Oncology Clinical Trials-Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions
    Ahaghotu, Chiledum
    Tyler, Robert
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2016, 14 (02) : 105 - 116
  • [37] Clinical empathy with cancer patients: a content analysis of oncology nurses' perception
    Rohani, Camelia
    Kesbakhi, Maryam Sedaghati
    Mohtashami, Jamileh
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1089 - 1098
  • [38] Health literacy and informed consent for clinical trials: a systematic review and implications for nurses
    Burks, Allison C.
    Keim-Malpass, Jessica
    NURSING-RESEARCH AND REVIEWS, 2019, 9 : 31 - 40
  • [39] Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland
    Kelly, C. M.
    Feighery, R.
    McCaffrey, J.
    Higgins, M.
    Smith, M.
    O'Reilly, S.
    Murphy, C.
    Horgan, A.
    Walshe, J.
    McDermott, R.
    O'Donnell, D.
    Morris, P. G.
    Keane, M.
    Martin, M.
    Duffy, K.
    Mihai, A.
    Armstrong, J.
    Mulroe, E.
    Murphy, V.
    Kelly, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Endpoints in oncology clinical trials
    Kilickap, Saadettin
    Demirci, Umut
    Karadurmus, Nuri
    Dogan, Mutlu
    Akinci, Bulent
    Sendur, Mehmet Ali Nahit
    JOURNAL OF BUON, 2018, 23 : S1 - S6